The specialist is responsible for providing comprehensive pharmacotherapy management for patients with solid malignancies, including optimization of antineoplastic therapy, supportive care interventions (e.g., antiemetics, hematopoietic growth factors, tumor lysis syndrome prophylaxis, and bone-modifying agents), management of immune-related adverse events, and prevention and mitigation of chemotherapy-related toxicities. Working within a paired specialist model alongside the Inpatient Malignant Hematology Clinical Pharmacy Specialist, this position provides comprehensive oncology pharmacy coverage across the four primary inpatient hematology/oncology teams (two teaching and two non-teaching services) as well as the two inpatient consult services (Solid Oncology and Hematology).